Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2004-08-20
2008-05-13
McGarry, Sean (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023100, C536S024300, C536S024330
Reexamination Certificate
active
07371850
ABSTRACT:
Methods and pharmaceutical compositions for treating, and delaying the onset of, viral infection, are provided.
REFERENCES:
patent: 6218410 (2001-04-01), Uehata et al.
patent: 6451825 (2002-09-01), Uehata et al.
patent: 6814968 (2004-11-01), Graham et al.
patent: 6906061 (2005-06-01), Uehata et al.
patent: 6977262 (2005-12-01), Kohara et al.
patent: 2002/0173622 (2002-11-01), Wettstein et al.
patent: 2002/0177207 (2002-11-01), Sugiyama et al.
patent: 2004/0115641 (2004-06-01), Cowsert et al.
patent: 2004/0138272 (2004-07-01), McKerracher et al.
patent: 2004/0191240 (2004-09-01), Tohyamay et al.
patent: 2004/0191291 (2004-09-01), Tohyamay et al.
patent: WO 2004/022541 (2004-03-01), None
Nakamura et al. Role of the small GTP-binding protien Rho in epithelial cell migration in the rabbit cornea. Invest Ophthalmol Via Sci, 2001 vol. 42:941-947.
Ishikawa et al. Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. DNA Research, 1998 vol. 5:169-176.
Shi, Y. Mammailian RNAi for the masses. Trends in Genetics, 2003 vol. 19:9-12.
Capodici et al. Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. Journal of Immunology. 2002 vol. 169:5196-5201.
GenBank Sequence-Accession No. AB014519, Jul. 15, 1998.
Akari, H. et al., “Suppression of HIV-1 replication in peripheral blood mononuclear cells by fasudil”,J. Med. Invest., 1998; 44:211-214.
Gower, T.L. et al., “RhoA Is Activated During Respiratory Syncytial Virus Infection”,Virology,2001, 283:188-196.
Kadowaki, S. et al.,“Down-regulation of inducible nitric oxide synthase by lysophosphatidic acid in human respiratory epithelial cells”,Mol. Cell Biochem., 2003, 262:51-59.
Nishimura, Y. et al., “Small guanosine triphosphatase Rho/Rho-associated kinase as a novel regulator of Intracellular redistribution of lysosomes in invasive tumor cells”,Cell Tissue Res., 2000, 301:341-351.
Okada, H. et al., “Inhibition of HIV-1 Nef-induced apoptosis of uninfected human blood cells by serine/threonine protein kinase inhibitors, fasudil hydrochloride and M3”,FEBS Letters., 1998; 422:363-367.
Okada, H. et al., “Nef protein of HIV-1 induces apoptotic cytolysis of murine lymphoid cells independently of CD95 (Fas) and its suppression by serine/threonine protein kinase inhibitors”,FEBS Letters., 1997:61-64.
Riento et al., “Rocks: Multifunctional Kinases in Cell Behaviour”,Nature, Jun. 2003, 4:446-456.
Sato, T. et al., “Inhibition of Human Immunodeficiency Virus Type 1 Replication by a Bioavailable Serine/Threonine Kinase Inhibitor, Fasudil Hydrochloride”,Aids Res. Hum. Retroviruses, 1998: 14(4):293-298.
He Gongping
Morham Scott
Gibbs Terra C.
Ley, III Herbert L.
McGarry Sean
Myriad Genetics Inc.
Myriad IP Department
LandOfFree
Method and composition for reducing expression of ROCK-II does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for reducing expression of ROCK-II, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for reducing expression of ROCK-II will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3983150